Cannara Biotech Inc. (TSXV:LOVE)

Cannara Biotech Income Statement

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 30, 2025	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Operating Revenue	111.99	106.86	81.65	57.07	35.48	16.29
Other Revenue	0.26	0.34	0.09	0.19	0.36	0.73
Revenue	112.25	107.2	81.75	57.26	35.84	17.02
Revenue Growth (YoY)	28.52%	31.14%	42.77%	59.76%	110.58%	567.25%
Cost of Revenue	64.11	60.1	51.96	30.03	18.51	6.72
Gross Profit	48.13	47.1	29.79	27.23	17.33	10.3
Selling, General & Admin	23.04	21.98	17.67	11.77	9.68	6.98
Research & Development	0.83	0.71	1.12	1.03	1.26	1.91
Amortization of Goodwill & Intangibles	-	1.56	1.38	0.96	1.23	1.03
Operating Expenses	28.01	25.44	22.14	15.51	12.51	10.24
Operating Income	20.13	21.66	7.64	11.72	4.82	0.05
Interest Expense	-3.32	-3.77	-4.85	-4.74	-2.23	-1.71
Interest & Investment Income	0.3	0.28	0.18	0.24	0.09	0.05
Currency Exchange Gain (Loss)	-0.05	-0	-0.12	0.07	0.03	-0.11
Other Non Operating Income (Expenses)	-0.47	-0.59	-0.82	-0.56	-0.53	-0.02
EBT Excluding Unusual Items	16.59	17.59	2.04	6.72	2.18	-1.73
Gain (Loss) on Sale of Assets	0.42	0.42	2.03	-0.13	-0.05	-0.07
Other Unusual Items	0.09	0.09	0.41	0.36	0.17	0.27
Pretax Income	17.1	18.1	4.48	6.95	2.31	-1.53
Income Tax Expense	5.29	5.02	-1.95	-	-	-
Earnings From Continuing Operations	11.81	13.08	6.44	6.95	2.31	-1.53
Net Income	11.81	13.08	6.44	6.95	2.31	-1.53
Net Income to Common	11.81	13.08	6.44	6.95	2.31	-1.53
Net Income Growth	77.94%	103.09%	-7.30%	201.26%	-	-
Shares Outstanding (Basic)	92	91	90	89	88	77
Shares Outstanding (Diluted)	94	92	91	90	88	77
Shares Change (YoY)	2.18%	1.08%	1.83%	2.16%	14.80%	7.26%
EPS (Basic)	0.13	0.14	0.07	0.08	0.03	-0.02
EPS (Diluted)	0.12	0.14	0.07	0.08	0.03	-0.10
EPS Growth	61.65%	100.00%	-10.00%	195.77%	-	-
Free Cash Flow	12.38	13.65	3.21	-3.97	-21.55	-33.17
Free Cash Flow Per Share	0.13	0.15	0.04	-0.04	-0.24	-0.43
Gross Margin	42.88%	43.94%	36.44%	47.56%	48.35%	60.49%
Operating Margin	17.93%	20.20%	9.35%	20.46%	13.45%	0.31%
Profit Margin	10.52%	12.20%	7.88%	12.13%	6.43%	-8.98%
Free Cash Flow Margin	11.03%	12.74%	3.93%	-6.93%	-60.11%	-194.86%
EBITDA	26.56	28.06	13.74	16.53	8.62	2.75
EBITDA Margin	23.66%	26.18%	16.81%	28.87%	24.06%	16.18%
D&A For EBITDA	6.43	6.4	6.1	4.82	3.8	2.7
EBIT	20.13	21.66	7.64	11.72	4.82	0.05
EBIT Margin	17.93%	20.20%	9.35%	20.46%	13.45%	0.31%
Effective Tax Rate	30.95%	27.74%	-	-	-	-
Revenue as Reported	112.36	107.32	82.15	57.56	36	17.27

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.